Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by NFJ Investment Group LLC

NFJ Investment Group LLC trimmed its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 1.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,736 shares of the company’s stock after selling 632 shares during the period. NFJ Investment Group LLC’s holdings in Surgery Partners were worth $1,095,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Principal Financial Group Inc. purchased a new position in Surgery Partners in the 3rd quarter valued at about $1,469,000. Geode Capital Management LLC lifted its position in shares of Surgery Partners by 2.4% in the third quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after acquiring an additional 42,897 shares in the last quarter. AlphaCentric Advisors LLC purchased a new position in shares of Surgery Partners in the fourth quarter valued at approximately $374,000. JPMorgan Chase & Co. boosted its stake in shares of Surgery Partners by 3.0% in the third quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company’s stock worth $6,107,000 after acquiring an additional 5,551 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of Surgery Partners during the fourth quarter worth approximately $15,796,000.

Surgery Partners Stock Performance

NASDAQ:SGRY opened at $21.22 on Friday. The company’s 50-day moving average is $23.63 and its two-hundred day moving average is $24.51. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $33.97. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm has a market capitalization of $2.71 billion, a price-to-earnings ratio of -44.21, a PEG ratio of 19.21 and a beta of 2.40.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.01. The firm had revenue of $864.40 million for the quarter, compared to analysts’ expectations of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SGRY. Macquarie decreased their price objective on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th. Royal Bank of Canada restated an “outperform” rating and set a $35.00 price target on shares of Surgery Partners in a research report on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $36.63.

Insider Activity at Surgery Partners

In other news, CFO David T. Doherty sold 13,641 shares of the firm’s stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.61, for a total transaction of $349,346.01. Following the completion of the transaction, the chief financial officer now directly owns 108,862 shares in the company, valued at $2,787,955.82. This trade represents a 11.14 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Marissa Brittenham sold 3,156 shares of the business’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the sale, the insider now owns 63,408 shares in the company, valued at $1,527,498.72. This represents a 4.74 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 106,622 shares of company stock worth $2,717,860. Company insiders own 2.30% of the company’s stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.